Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MEETINGS - Regulatory Affairs Professional Society (RAPS) hosts the following conferences (Belgium) September 2002:

This article was originally published in Clinica

Executive Summary

The Regulatory Affairs Professional Society (RAPS) is hosting two simultaneous conferences on Principles and Practices of Regulatory Affairs on September 12-13 2002 at the Sheraton Brussels Hotel & Towers, Brussels, Belgium. One will address EU regulatory affairs and the other US regulatory affairs. The EU course will review the fundamentals of the regulatory requirements for medical products in the EU. Topics include marketing authorisations, applicable directives, competent authorities, CE marking, notified bodies, future harmonisation efforts and proposed legislative changes. The US conference will contrast US regulatory requirements for drugs, medical devices and biologics. It will cover product development processes, preclinical and clinical considerations, marketing applications, post-marketing requirements and the enforcement of regulations across product lines. Further details from RAPS, on tel: +1 301 770 2920; fax: +1 301 770 2924; email: raps news @ raps . org www. raps. org

You may also be interested in...

ECHA Deliberates On Final Microplastic Proposal As Beauty Industry’s Fate Hangs In Balance

A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.

QUOTED. 2 December. Laurent Faracci.

Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.

Health Care Personnel, Long-Term Care Residents Should Get COVID-19 Vaccine First, ACIP Votes

CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts